
- /
- Supported exchanges
- / US
- / TXMD.NASDAQ
TherapeuticsMD Inc (TXMD NASDAQ) stock market data APIs
TherapeuticsMD Inc Financial Data Overview
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get TherapeuticsMD Inc data using free add-ons & libraries
Get TherapeuticsMD Inc Fundamental Data
TherapeuticsMD Inc Fundamental data includes:
- Net Revenue: 1 841 K
- EBITDA: -2 662 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-08
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
TherapeuticsMD Inc News

12 Best Prenatal Vitamins For Pregnant Women
In this article, we will be taking a look at the 12 best prenatal vitamins for pregnant women. If you are not interested in reading about the market insights, head straight to the 5 Best Prenatal Vita...


TherapeuticsMD Announces Third Quarter 2023 Financial Results
Focus remains on cost control to maximize the value of our royalty assets Company announces evaluation of strategic alternatives BOCA RATON, Fla., November 14, 2023--(BUSINESS WIRE)--TherapeuticsMD, ...

TherapeuticsMD Announces Second Quarter 2023 Financial Results
BOCA RATON, Fla., August 14, 2023--(BUSINESS WIRE)--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported fina...

TherapeuticsMD Announces First Quarter 2023 Financial Results
BOCA RATON, Fla., May 15, 2023--(BUSINESS WIRE)--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financi...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.